Pain
News from the FDA/CDC
FDA warning letters target OTC cannabidiol product claims for pain relief
The FDA sent warning letters to two manufacturers for illegal marketing of drugs containing cannabidiol (CBD) and a failure to comply with current...
From the Journals
Cannabinoids may pose death risk for older patients with COPD
All-cause mortality significantly increased in COPD patients aged 66 years and older after starting nabilone or dronabinol.
Feature
Women increasingly turn to CBD, with or without doc’s blessing
Women of reproductive age are increasingly turning to cannabinoids to treat gynecologic and other conditions. A study shows they’re not waiting...
From the Journals
Opioid-related deaths lower in counties with active cannabis dispensaries
Evidence of a negative association between legalization of medical or recreational cannabis and opioid-related mortality has been mixed.
Feature
Tough pain relief choices in the COVID-19 pandemic
From the Journals
PCPs play a small part in low-value care spending
Study indicates waste was widely distributed among specialties.
From the Journals
Children’s opioid harms vary by race, location
Analysis of North Carolina Medicaid data separates opioid-related poisoning or withdrawal from abuse or dependence.
From the Journals
‘Overwhelming evidence’ FDA’s opioid approval process is shoddy
The majority of approvals of opioids for the treatment of chronic pain during 1997-2018 were based on pivotal trials that lacked critical safety...
FDA/CDC
FDA orders stronger warnings on benzodiazepines
"While benzodiazepines are important therapies for many Americans, they are also commonly abused and misused," said Commissioner Stephen M. Hahn,...
Commentary
New acute pain guidelines from the ACP and AAFP have limitations
Pain can be multi-factorial and treating it requires a multi-pronged approach.
FDA/CDC
Reworked OxyContin fails to cut overall opioid abuse, FDA panel says
Some members noted that reformulated OxyContin coincided with increased transition to heroin but recognized the difficulty of proving causality....